Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Medical System Holdings ( (HK:0867) ) has shared an announcement.
China Medical System Holdings Limited announced a 10.8% increase in turnover and a 3.1% rise in profit for the first half of 2025, driven by the growth of major exclusive and branded products. The company achieved a significant milestone by completing its secondary listing on the SGX-ST, enhancing its brand influence and establishing an integrated ecosystem to capture growth potential in emerging markets.
The most recent analyst rating on (HK:0867) stock is a Buy with a HK$14.33 price target. To see the full list of analyst forecasts on China Medical System Holdings stock, see the HK:0867 Stock Forecast page.
More about China Medical System Holdings
China Medical System Holdings Limited (CMS) is a pharmaceutical company incorporated in the Cayman Islands, focusing on the commercialization of innovative drugs and healthcare products. The company operates in specialty therapeutic fields and has a significant presence in the skin health segment, with a growing influence in Southeast Asia and international markets.
YTD Price Performance: 81.52%
Average Trading Volume: 15,873,890
Technical Sentiment Signal: Buy
Current Market Cap: HK$32.93B
See more insights into 0867 stock on TipRanks’ Stock Analysis page.